Health workers sceptical about the quality of PPEs: survey
Staff Correspondent, bdnews24.com
Published: 18 Apr 2020 05:29 PM BdST Updated: 18 Apr 2020 05:30 PM BdST
Twenty-five percent of doctors and 60 percent of nurses engaged in treating coronavirus patients have not yet received personal protective equipment, or PPEs, and those who have are sceptical of its effectiveness, according to a survey.
The findings were made public in a virtual media briefing on Saturday by BRAC University’s James P Grant School of Public Health and Bangladesh Health Watch.
"Seventy-five percent of frontline doctors and 40 percent of the nurses have received PPEs. However, they are sceptical about the quality of the raincoat-like PPEs,” said Bushra Zerin Islam, a researcher involved in the survey.
“The World Health Organisation recommends the PPEs to be used once and then destroyed. But our health workers are being told to reuse their equipment. These issues are causing a great deal of stress among the health workers.”

Researchers said 60 doctors and nurses from 43 hospitals and health centres in 14 districts participated in the survey by telephone. The survey was conducted from Apr 9-14.
Another survey was conducted by BRAC University’s School of Public Health about the coronavirus awareness level among the people.
There is a serious lack of awareness about the disease, said researcher Atanu Rabbani.
“A lot of people still do not know how the disease spreads.”
High levels of fear and panic were seen among the poor of Dhaka city and the Hijra population regarding the coronavirus, according to two surveys conducted among slum dwellers and Hijras.
“The Hijra community has been speculating that they will not receive any treatment and will die from the disease. Their income is also taking a hit. Since they travel in groups, they are being thought of as carriers of the virus. They are becoming even more marginalised now,” said Bachera Aktar, a researcher.
-
A new virus variant is spreading in NY: experts
-
J&J's one-shot COVID vaccine effective, safe
-
Singapore trials Smartphone app offering mini check-ups
-
AstraZeneca to miss Q2 EU vaccine supply target by half
-
105-year-old credits gin-soaked raisins after beating COVID
-
70pc drop in virus infections after first Pfizer shot: UK
-
GSK, Sanofi start new vaccine study
-
Serum 'prioritising' domestic vaccine needs
-
A new coronavirus variant is spreading in New York, researchers report
-
Johnson & Johnson's one-shot COVID-19 vaccine effective, safe: FDA staff
-
Singapore trials Smartphone app offering mini check-ups
-
AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official
-
This 105-year-old beat COVID. She credits gin-soaked raisins
-
'Real-world' UK data shows 70% decline in COVID infections after first Pfizer shot
Most Read
- Cricketer Nasir, wife Tamima charged in case filed by her first husband Rakib
- How to register for coronavirus vaccine in Bangladesh
- Bangladesh inoculates older sex workers at biggest brothel
- Relief secretary contracts virus 12 days after vaccination
- PBI to investigate case against Nasir, wife Tamima by her first husband Rakib
- After pressure to remove old reports, bdnews24.com faces plea for defamation suit
- Supporters of Myanmar military coup rampage in Yangon
- Bangladesh observes 12th anniversary of Peelkhana carnage
- ‘COVID zero’ is unattainable; acceptable risk is the goal
- US should appoint special envoy on Rohingya: Bangladesh FM to Blinken